AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Enhanced Valves Interventions and Safe AI Generated End Results

Recruitingn/aAges 18 Years - anyAllMontreal Heart Institute
💬

In plain words

What the trial is, and whether it could suit you

This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Patients who have reached the age of legal majority under local laws. * For TAVI group: All patients who have had TAVI with a third generation transcatheter heart valve (THV), with an available pre-procedural optimal quality CT scan as defined by an ECG- gating CT with: 1. five to ten image volumes at cardiac phases from 5% to 95% R-R 2. 0.625 mm slice thickness 3. 0.625 mm spacing between slices 4. 0.88 mm in-plane pixel spacing * For TMVI group: Patients who have had a TMVI with a dedicated device and screen failures, with an available optimal quality CT scan. * For TTVI group: Patients who have had a TTVI with a dedicated device and screen failures, with an available optimal quality CT scan. * For M-TEER: All patient who have had a M-TEER with 1) G4 or newer iteration of MitraClip or 2) G2 or newer iteration of Pascal, with available pre-procedural TEE videos images from one of two vendors: Phillips or GE, with clear identifiable views of the Mitral valve, frame per second equal or higher than 40 frames per second, acceptable 3D reconstructions. * For T-TEER: All patient who have had a T-TEER with G4 or newer iteration of TriClip or 2) G2 or newer iteration of Pascal, with available pre-procedural TEE videos images from one of two vendors: Phillips or GE, with clear identifiable views of the Tricuspid valve, frame per second equal or higher than 40 frames per second, acceptable transgastric image with acceptable 3D reconstructions. Exclusion Criteria: * For TAVI group: Valve-in-valve procedures * For TMVI group: Valve-in-valve and valve-in-ring procedures * For TTVI: Valve-in-valve and valve-in-ring procedures * For M-TEER: G3 or older MitraClip, G1 Pascal * For T-TEER: G3 Triclip, G1 Pascal
💊

What it tests

  • Medical imaging analysis via artificial intelligence algorithms
📍

Where

15 sites
Montefiore Medical Center New York
New York, United States
Montreal Heart Institute, 5000 Rue Bélanger, Montréal
Montreal, Canada
St Michael's Hospital Toronto
Toronto, Canada
St Paul's Hospital Vancouver
Vancouver, Canada
Centre Hospitalier Universitaire (CHU) de Bordeaux, 12 rue Dubernat 33404 Talence cedex
Bourdeaux, France
CHU Lille
Lille, France
CHU Marseille
Marseille, France
Centre Cardiologique du Nord Paris
Paris, France

…and 7 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy